Literature DB >> 33556121

Unraveling the chaotic genomic landscape of primary and metastatic canine appendicular osteosarcoma with current sequencing technologies and bioinformatic approaches.

Shirley Chu1, Zachary L Skidmore2, Jason Kunisaki2, Jason R Walker2, Malachi Griffith2,3, Obi L Griffith2,3, Jeffrey N Bryan1.   

Abstract

Osteosarcoma is a rare disease in children but is one of the most common cancers in adult large breed dogs. The mutational landscape of both the primary and pulmonary metastatic tumor in two dogs with appendicular osteosarcoma (OSA) was comprehensively evaluated using an automated whole genome sequencing, exome and RNA-seq pipeline that was adapted for this study for use in dogs. Chromosomal lesions were the most common type of mutation. The mutational landscape varied substantially between dogs but the lesions within the same patient were similar. Copy number neutral loss of heterozygosity in mutant TP53 was the most significant driver mutation and involved a large region in the middle of chromosome 5. Canine and human OSA is characterized by loss of cell cycle checkpoint integrity and DNA damage response pathways. Mutational profiling of individual patients with canine OSA would be recommended prior to targeted therapy, given the heterogeneity seen in our study and previous studies.

Entities:  

Mesh:

Year:  2021        PMID: 33556121      PMCID: PMC7870011          DOI: 10.1371/journal.pone.0246443

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  103 in total

1.  Status of the p53, Rb and MDM2 genes in canine osteosarcoma.

Authors:  S Mendoza; T Konishi; W S Dernell; S J Withrow; C W Miller
Journal:  Anticancer Res       Date:  1998 Nov-Dec       Impact factor: 2.480

2.  The MTAP-CDKN2A locus confers susceptibility to a naturally occurring canine cancer.

Authors:  Abigail L Shearin; Benoit Hedan; Edouard Cadieu; Suzanne A Erich; Emmett V Schmidt; Daniel L Faden; John Cullen; Jerome Abadie; Erika M Kwon; Andrea Gröne; Patrick Devauchelle; Maud Rimbault; Danielle M Karyadi; Mary Lynch; Francis Galibert; Matthew Breen; Gerard R Rutteman; Catherine André; Heidi G Parker; Elaine A Ostrander
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-05-23       Impact factor: 4.254

3.  Mutations of the CHK2 gene are found in some osteosarcomas, but are rare in breast, lung, and ovarian tumors.

Authors:  Carl W Miller; Takayuki Ikezoe; Utz Krug; Wolf-K Hofmann; Sigal Tavor; Vijaya Vegesna; Kunihiro Tsukasaki; Seisho Takeuchi; H Phillip Koeffler
Journal:  Genes Chromosomes Cancer       Date:  2002-01       Impact factor: 5.006

4.  Height at diagnosis and birth-weight as risk factors for osteosarcoma.

Authors:  Lisa Mirabello; Ruth Pfeiffer; Gwen Murphy; Najat C Daw; Ana Patiño-Garcia; Rebecca J Troisi; Robert N Hoover; Chester Douglass; Joachim Schüz; Alan W Craft; Sharon A Savage
Journal:  Cancer Causes Control       Date:  2011-04-05       Impact factor: 2.506

5.  Altered-function p53 missense mutations identified in breast cancers can have subtle effects on transactivation.

Authors:  Jennifer J Jordan; Alberto Inga; Kathleen Conway; Sharon Edmiston; Lisa A Carey; Lin Wu; Michael A Resnick
Journal:  Mol Cancer Res       Date:  2010-04-20       Impact factor: 5.852

6.  Fas expression inversely correlates with metastatic potential in osteosarcoma cells.

Authors:  Laura L Worth; Elizabeth A Lafleur; Shu-Fang Jia; Eugenie S Kleinerman
Journal:  Oncol Rep       Date:  2002 Jul-Aug       Impact factor: 3.906

7.  Genome-wide analyses implicate 33 loci in heritable dog osteosarcoma, including regulatory variants near CDKN2A/B.

Authors:  Elinor K Karlsson; Snaevar Sigurdsson; Emma Ivansson; Rachael Thomas; Ingegerd Elvers; Jason Wright; Cedric Howald; Noriko Tonomura; Michele Perloski; Ross Swofford; Tara Biagi; Sarah Fryc; Nathan Anderson; Celine Courtay-Cahen; Lisa Youell; Sally L Ricketts; Sarah Mandlebaum; Patricio Rivera; Henrik von Euler; William C Kisseberth; Cheryl A London; Eric S Lander; Guillermo Couto; Kenine Comstock; Mike P Starkey; Jaime F Modiano; Matthew Breen; Kerstin Lindblad-Toh
Journal:  Genome Biol       Date:  2013-12-12       Impact factor: 13.583

Review 8.  Comparative review of human and canine osteosarcoma: morphology, epidemiology, prognosis, treatment and genetics.

Authors:  Siobhan Simpson; Mark David Dunning; Simone de Brot; Llorenç Grau-Roma; Nigel Patrick Mongan; Catrin Sian Rutland
Journal:  Acta Vet Scand       Date:  2017-10-24       Impact factor: 1.695

Review 9.  Risk Factors for Development of Canine and Human Osteosarcoma: A Comparative Review.

Authors:  Kelly M Makielski; Lauren J Mills; Aaron L Sarver; Michael S Henson; Logan G Spector; Shruthi Naik; Jaime F Modiano
Journal:  Vet Sci       Date:  2019-05-25

10.  Fast and accurate short read alignment with Burrows-Wheeler transform.

Authors:  Heng Li; Richard Durbin
Journal:  Bioinformatics       Date:  2009-05-18       Impact factor: 6.937

View more
  1 in total

1.  The genomic landscape of canine osteosarcoma cell lines reveals conserved structural complexity and pathway alterations.

Authors:  Kate Megquier; Jason Turner-Maier; Kathleen Morrill; Xue Li; Jeremy Johnson; Elinor K Karlsson; Cheryl A London; Heather L Gardner
Journal:  PLoS One       Date:  2022-09-13       Impact factor: 3.752

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.